Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
August 07, 2024 16:05 ET
|
Alector, Inc.
Data from INVOKE-2 Phase 2 clinical trial of AL002 in individuals with early Alzheimer’s disease (AD) on track for Q4 2024 Patient baseline characteristics data for the INVOKE-2 trial confirm the...